Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitemicrobix.com
CategoryBioTech
Phone905-361-8910
Emailmicrobix@microbix...
Employees
Founded1988

Offices

Ontario, CAN
265 Watline Avenue
Mississauga
Ontario, L4Z 1P3, CAN

People

Funding

TOTAL $2.13M
FUNDING TOTAL $2.13M
Venture Round, 9/2009
$88.1k
Venture Round, 3/2010
$296k
Venture Round, 8/2011
$248k
Convertible Note, 2/2014
$1.5M

Tags

Microbix Biosystems

Watline Avenue | Microbix Biosystems Inc. Microbix Biosystems Inc. develops biological products and technologies. The Company was founded in 1988 as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies including VIRUSMAX (Influenza Virus Yield Enhancement Technology), LumiSort™ (Semen Sexing Technology) and the thrombolytic drug, Kinlytic® (Urokinase). Funded by income from the antigen business, the pipeline products take aim at large market opportunities. With Microbix’ core competencies in the Infectious Disease Antigen business, including cell culture, molecular biology, and a GMP quality system, the pipeline products build on Microbix’ strength.

Recent Milestones

Videos

Screenshots

Microbix Biosystems screenshot
Above: Homepage
Uploaded: 10/7/13

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Microbix Closes Financing for Lumisort Prototype (newswire.ca) [edit]
Edit This Page
Last Edited 2/20/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy